ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000235117.2	ABT-263 (navitoclax)	Sarcoma	0.045625654	Resistant
ENSG00000235117.2	ABT-263 (navitoclax)	Skin cutaneous melanoma	0.045654637	Resistant